Clinical trial
SECURE polypill
NCT02596126
Aspirin + ramipril + atorvastatin vs usual care after recent MI, median 36 months, primary MACE HR 0.76 (0.60–0.96). Castellano et al. N Engl J Med 2022;387:967-977.
No news refers to this card yet.
Also in the catalogue
- SELECT (semaglutide 2.4 mg), frailty post-hoc analysisClinical trial
- SOUL (oral semaglutide)Clinical trial
- PIEZO-101 (Piezo Therapeutics)Clinical trial
- Finerenone vs placebo in premature ovarian insufficiencyClinical trial
- FIDELIO-DKD (finerenone)Clinical trial
- FINEARTS-HF (finerenone)Clinical trial
Scales
Identifiers
- NCT
- NCT02596126
Original sources
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.